至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

LncRNA HOXA11-AS promotes cell growth by sponging miR-24-3p to regulate JPT1 in prostate cancer

Eur Rev Med Pharmacol Sci. 2021-07; 
Y Cheng, H-Y Xiong, Y-M Li, H-R Zuo, Y Liu, G-L Liao
Products/Services Used Details Operation
Gene Synthesis NA3.1 contains full sequence of HOXA11-AS (pHOXA11-AS) or JPT1 (pJPT1) was purchased at GenScript (Nanjing, China). Get A Quote

摘要

objective: Long noncoding RNA (lncRNA) was found to play crucial roles in regulating cancer progression. HOXA11 antisense RNA (HOXA11-AS) was reported to serve an oncogenic lncRNA in cancers but its role in prostate cancer (PCa) remains to be explored. methods: Expression levels of HOXA11-AS in PCa tissues and cells were analyzed with quantitative Real-Time PCR method. MTT assay, colony formation assay, transwell invasion assay, and flow cytometry assay were conducted to explore the biological roles of HOXA11-AS in PCa. Rescue experiments were conducted to investigate mechanisms of HOXA11-AS in regulating PCa progression. results: We revealed that HOXA11-AS was upregulated in PCa. Silencing of HOXA11-AS signifi... More

关键词